TS-011 structure
|
Common Name | TS-011 | ||
---|---|---|---|---|
CAS Number | 339071-18-0 | Molecular Weight | 255.70100 | |
Density | N/A | Boiling Point | 477.8±55.0°C | |
Molecular Formula | C11H14ClN3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of TS-011TS-011 is a selective inhibitor of 20-Hydroxyeicosatetraenoic acid synthesis. |
Name | N'-(3-chloro-4-morpholin-4-ylphenyl)-N-hydroxymethanimidamide |
---|---|
Synonym | More Synonyms |
Description | TS-011 is a selective inhibitor of 20-Hydroxyeicosatetraenoic acid synthesis. |
---|---|
Related Catalog | |
In Vivo | TS-011 is a selective inhibitor of 20-Hydroxyeicosatetraenoic acidsynthesis. TS-011 at a dose of 0.3 mg/kg inhibits the reduction in the blood flow velocities at 1 and 7 h after reperfusion (P<0.001). In addition, TS-011 inhibits the increase in the blood flow velocity at 24 h after reperfusion (P<0.01). TS-011 protects the microvascular perfusion area from the loss observed in vehicle-treated mice. TS-011, at a dose of 0.3 mg/kg, also reduces the infarct volume by almost 40% (P<0.05)[1]. In 9 dogs with delayed vasospasm, acute blockade of the synthesis of 20-HETE with TS-011 (1 mg/kg IV) significantly increases the diameter of the basilar artery by 39%[2]. |
Animal Admin | The studies are performed using 58 male C57BL/6J mice (8 weeks old) weighing 20 to 26 g. TS-011 (0.3 mg/kg) or a vehicle is infused intravenously for 1 h every 6 h in a mouse model of stroke, induced by transient occlusion of the middle cerebral artery occlusion following photothrombosis. The cerebral blood flow velocity and the vascular perfusion area of the peri-infarct microvessels are measured using in vivo two-photon imaging[1]. |
References |
Boiling Point | 477.8±55.0°C |
---|---|
Molecular Formula | C11H14ClN3O2 |
Molecular Weight | 255.70100 |
Exact Mass | 255.07700 |
PSA | 57.09000 |
LogP | 2.27110 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|
TS-011 |
Methanimidamide,N-[3-chloro-4-(4-morpholinyl)phenyl]-N'-hydroxy |